Where are they now? 4 biotechs that soared then crashed during the pandemic

As quickly as they rose to prominence during the pandemic, many biotechs fell just as rapidly back down to earth.

When pharma’s R&D push peaked, hundreds of vaccines and treatments were in development to combat the novel coronavirus. And while the remobilization turned once-obscure biotechs like Moderna into household names, a host of other companies that had suddenly emerged into the spotlight ultimately faded as their candidates faltered.